Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Show full CV Hide full CV

Latest news & insights

Corporate/M&A & capital markets

Taylor Wessing advises Sunday Natural on the sale of a stake to CVC

16 January 2024

by multiple authors

Click here to find out more
Patents & innovation

Higher Administrative Court of Münster: Subsequent authorization of a homeopathic medicinal product

19 December 2023
Briefing

by Dr. Daniel Tietjen and Katharina Hölle

Click here to find out more
Brands & advertising

Regional Court of Karlsruhe: Advertising with the claims "climate-neutral" and "environmentally neutral product"

18 December 2023
Quick read

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Click here to find out more
Brands & advertising

Higher Regional Court of Hamburg: Differentiation between corporate advertising and sales advertising relevant under pharmaceutical law

18 December 2023
Briefing

by Dr. Daniel Tietjen and Katharina Hölle

Click here to find out more

Meet me at

There are no upcoming events